Abstract
BACKGROUND/AIMS—There are no nationally agreed guidelines on preoperative management of patients who are on aspirin or warfarin therapy. There is considerable evidence that complication rates in anticoagulated patients are low whereas there are higher rates of thromboembolic complications in those whose therapy is manipulated. This survey aimed to establish oculoplastic specialist and non-specialist ophthalmic surgeons' current management practice of patients before oculoplastic surgery who are taking aspirin or warfarin and to assess the rate of complications in these patients. METHOD—An anonymous postal questionnaire survey of all ophthalmic consultants and specialist registrars in the Wessex region along with oculoplastic specialists in the Southern region. RESULTS—The overall response rate was 92%. Preoperative management was influenced both by type of operation and by type of surgeon. A statistically significant higher proportion of surgeons would consider altering warfarin compared with aspirin treatment. For all procedures, non-specialists are unlikely to stop aspirin therapy, and are less likely to stop warfarin before all procedures apart from dacrocystorhinostomy. A significant proportion of surgeons (18%) would allow insufficient time for the coagulation status of the patient to change after altering treatment. A considerable proportion of surgeons (54%) reported that they had seen complications as a result either of stopping or continuing anticoagulation therapy. CONCLUSIONS—In this survey, at least half the surgeons questioned would consider stopping warfarin before oculoplastic procedures. Over half of all surgeons have seen complications related to aspirin or warfarin, some of which were serious. A suggested approach to minimising patient risk is given.
Full Text
The Full Text of this article is available as a PDF (87.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bartley G. B. Oculoplastic surgery in patients receiving warfarin: suggestions for management. Ophthal Plast Reconstr Surg. 1996 Dec;12(4):229–230. doi: 10.1097/00002341-199612000-00001. [DOI] [PubMed] [Google Scholar]
- Carter K., Miller K. M. Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg. 1998 Oct;24(10):1361–1364. doi: 10.1016/s0886-3350(98)80229-0. [DOI] [PubMed] [Google Scholar]
- Dick B., Jacobi F. K. Kataraktchirurgie und Antikoagulation--derzeitiger Stand. Klin Monbl Augenheilkd. 1996 Dec;209(6):340–346. doi: 10.1055/s-2008-1035331. [DOI] [PubMed] [Google Scholar]
- Eke T., Thompson J. R. The National Survey of Local Anaesthesia for Ocular Surgery. I. Survey methodology and current practice. Eye (Lond) 1999 Apr;13(Pt 2):189–195. doi: 10.1038/eye.1999.49. [DOI] [PubMed] [Google Scholar]
- Eke T., Thompson J. R. The National Survey of Local Anaesthesia for Ocular Surgery. II. Safety profiles of local anaesthesia techniques. Eye (Lond) 1999 Apr;13(Pt 2):196–204. doi: 10.1038/eye.1999.50. [DOI] [PubMed] [Google Scholar]
- Gainey S. P., Robertson D. M., Fay W., Ilstrup D. Ocular surgery on patients receiving long-term warfarin therapy. Am J Ophthalmol. 1989 Aug 15;108(2):142–146. doi: 10.1016/0002-9394(89)90008-1. [DOI] [PubMed] [Google Scholar]
- Gohlke-Bärwolf C., Acar J., Burckhardt D., Oakley C., Butchart E., Krayenbühl P., Hall R., Bodnar E., Krzeminska-Pakula M., Delahaye J. P. Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology. J Heart Valve Dis. 1993 Jul;2(4):398–410. [PubMed] [Google Scholar]
- Kammann J., Dornbach G., Linares I., Schüttrumpf R. Linsenimplantation bei Patienten unter Antikoagulantientherapie. Ophthalmologe. 1994 Aug;91(4):486–489. [PubMed] [Google Scholar]
- Moll A. C., van Rij G., van der Loos T. L. Anticoagulant therapy and cataract surgery. Doc Ophthalmol. 1989 Aug;72(3-4):367–373. doi: 10.1007/BF00153505. [DOI] [PubMed] [Google Scholar]
- Shuler J. D., Paschal J. F., Holland G. N. Antiplatelet therapy and cataract surgery. J Cataract Refract Surg. 1992 Nov;18(6):567–571. doi: 10.1016/s0886-3350(13)80444-0. [DOI] [PubMed] [Google Scholar]
- Stone L. S., Kline O. R., Jr, Sklar C. Intraocular lenses and anticoagulation and antiplatelet therapy. J Am Intraocul Implant Soc. 1985 Mar;11(2):165–168. doi: 10.1016/s0146-2776(85)80013-6. [DOI] [PubMed] [Google Scholar]